These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 15177939

  • 1. Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
    Tovote P, Meyer M, Beck-Sickinger AG, von Hörsten S, Ove Ogren S, Spiess J, Stiedl O.
    Regul Pept; 2004 Aug 15; 120(1-3):205-14. PubMed ID: 15177939
    [Abstract] [Full Text] [Related]

  • 2. Corticotropin-releasing factor receptor 1 and central heart rate regulation in mice during expression of conditioned fear.
    Stiedl O, Meyer M, Jahn O, Ogren SO, Spiess J.
    J Pharmacol Exp Ther; 2005 Mar 15; 312(3):905-16. PubMed ID: 15537825
    [Abstract] [Full Text] [Related]

  • 3. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S, Li DL, Simmons RM.
    J Pharmacol Exp Ther; 1999 May 15; 289(2):1031-40. PubMed ID: 10215684
    [Abstract] [Full Text] [Related]

  • 4. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
    Henry M, Ghibaudi L, Gao J, Hwa JJ.
    Obes Res; 2005 Jan 15; 13(1):36-47. PubMed ID: 15761161
    [Abstract] [Full Text] [Related]

  • 5. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
    Sørensen G, Lindberg C, Wörtwein G, Bolwig TG, Woldbye DP.
    J Neurosci Res; 2004 Sep 01; 77(5):723-9. PubMed ID: 15352219
    [Abstract] [Full Text] [Related]

  • 6. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
    El Bahh B, Balosso S, Hamilton T, Herzog H, Beck-Sickinger AG, Sperk G, Gehlert DR, Vezzani A, Colmers WF.
    Eur J Neurosci; 2005 Sep 01; 22(6):1417-30. PubMed ID: 16190896
    [Abstract] [Full Text] [Related]

  • 7. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
    Deo GS, Dandekar MP, Upadhya MA, Kokare DM, Subhedar NK.
    Brain Res; 2010 Mar 08; 1318():77-86. PubMed ID: 20059983
    [Abstract] [Full Text] [Related]

  • 8. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.
    Chu DQ, Cox HM, Costa SK, Herzog H, Brain SD.
    Br J Pharmacol; 2003 Sep 08; 140(2):422-30. PubMed ID: 12970079
    [Abstract] [Full Text] [Related]

  • 9. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
    Dimitrijević M, Stanojević S, Vujić V, Beck-Sickinger A, von Hörsten S.
    Regul Pept; 2005 Jan 15; 124(1-3):163-72. PubMed ID: 15544855
    [Abstract] [Full Text] [Related]

  • 10. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
    Tu B, Jiao Y, Herzog H, Nadler JV.
    Neuroscience; 2006 Dec 28; 143(4):1085-94. PubMed ID: 17027162
    [Abstract] [Full Text] [Related]

  • 11. Neuropeptide Y induces gonadotropin-releasing hormone gene expression directly and through conditioned medium from mHypoE-38 NPY neurons.
    Dhillon SS, Gingerich S, Belsham DD.
    Regul Pept; 2009 Aug 07; 156(1-3):96-103. PubMed ID: 19371763
    [Abstract] [Full Text] [Related]

  • 12. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
    Gehlert DR, Schober DA, Morin M, Berglund MM.
    Biochem Pharmacol; 2007 Dec 03; 74(11):1652-64. PubMed ID: 17897631
    [Abstract] [Full Text] [Related]

  • 13. Role of NPY Y1 receptor on acquisition, consolidation and extinction on contextual fear conditioning: dissociation between anxiety, locomotion and non-emotional memory behavior.
    Lach G, de Lima TC.
    Neurobiol Learn Mem; 2013 Jul 03; 103():26-33. PubMed ID: 23603424
    [Abstract] [Full Text] [Related]

  • 14. Selective activation of central NPY Y1 vs. Y5 receptor elicits hyperinsulinemia via distinct mechanisms.
    Gao J, Ghibaudi L, Hwa JJ.
    Am J Physiol Endocrinol Metab; 2004 Oct 03; 287(4):E706-11. PubMed ID: 15187000
    [Abstract] [Full Text] [Related]

  • 15. Region specific galanin receptor/neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption.
    Parrado C, Díaz-Cabiale Z, García-Coronel M, Agnati LF, Coveñas R, Fuxe K, Narváez JA.
    Neuropharmacology; 2007 Feb 03; 52(2):684-92. PubMed ID: 17087983
    [Abstract] [Full Text] [Related]

  • 16. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function.
    Gehlert DR, Shaw JL.
    Peptides; 2007 Feb 03; 28(2):241-9. PubMed ID: 17208335
    [Abstract] [Full Text] [Related]

  • 17. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
    Malmström RE, Balmér KC, Lundberg JM.
    Br J Pharmacol; 1997 Jun 03; 121(3):595-603. PubMed ID: 9179405
    [Abstract] [Full Text] [Related]

  • 18. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
    Lin EJ, Young D, Baer K, Herzog H, During MJ.
    Epilepsia; 2006 Apr 03; 47(4):773-80. PubMed ID: 16650144
    [Abstract] [Full Text] [Related]

  • 19. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
    Morris MJ, Gannan E, Stroud LM, Beck-Sickinger AG, O'Brien TJ.
    Eur J Neurosci; 2007 Feb 03; 25(4):1136-43. PubMed ID: 17331209
    [Abstract] [Full Text] [Related]

  • 20. Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstem.
    Grundemar L, Wahlestedt C, Reis DJ.
    J Pharmacol Exp Ther; 1991 Aug 03; 258(2):633-8. PubMed ID: 1678015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.